Novabay Pharmaceuticals IncのSMA 200
Novabay Pharmaceuticals IncのSMA 200は何ですか。
Novabay Pharmaceuticals IncのSMA 200は$7 -1,359.54%です。
SMA 200の定義は何ですか。
SMA 200は、過去200日間の終値の非加重平均として計算された過去200日間の平均株価です。
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
NYSEMKTのセクタHealth CareにおけるSMA 200の企業と比べるNovabay Pharmaceuticals Inc
Novabay Pharmaceuticals Incは何をしますか。
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Novabay Pharmaceuticals Incと類似のsma 200
- SGのSMA 200はHKD$7 +12.69%です。
- Canopy GrowthのSMA 200は$7 -48.34%です。
- Tidewater Renewables LtdのSMA 200はCAD$7 -140.97%です。
- Under ArmourのSMA 200は$7 -8.87%です。
- PCTEL IncのSMA 200は$7 +0.00%です。
- Picton Mahoney Tactical Income FundのSMA 200はCAD$7 +3.15%です。
- Novabay Pharmaceuticals IncのSMA 200は$7 -1,359.54%です。
- Leverage Shares 3x Facebook ETCのSMA 200は$7 -2.20%です。
- Melco Resorts & Entertainment LtdのSMA 200は$7 -27.49%です。
- Morgan HldgのSMA 200は$7 +30.00%です。
- Taiwan LiposomeのSMA 200は$7 +0.00%です。
- Immo-Antares NVのSMA 200は€7 +0.00%です。
- Value ETFs Trust - Value China A-Share ETFのSMA 200は¥7 -0.07%です。